Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.20

$0.00 (0.00%)

At close: Oct 30, 2026, 3:59 PM ET

$10.19

-$0.01 (-0.10%)

After-hours: Oct 30, 2026, 4:02 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $649.74M

Enterprise Value $650.02M

Beta 0.04

Average Volume 110.59K

Shares Outstanding (Diluted) 50M

Shares Change YoY 50.56%

Institutional Ownership 90.96%

Exchange NASDAQ

ISIN KYG2851K1040

Price Performance

Price Change 1M 0.2%

Price Change 3M 0.9%

Price Change 6M 1.8%

Price Change YTD 3.0%

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 0.3%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR 3.6%

Valuation

PE Ratio 35.17

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 1.31

P/FCF Ratio -507.28

P/Adj. FCF Ratio -507.28

P/OCF Ratio -510.00

EV/Sales N/A

EV/EBIT -449.11

EV/EBITDA -449.11

EV/FCF -507.49

Earnings Yield 2.8%

FCF Yield -0.2%

Adj. FCF Yield -0.2%

Financial Health

Net Debt $275.03K

Total Debt $450K

Cash & Short-Term Investments $174.97K

Total Assets $514.1M

Current Ratio 0.34

Quick Ratio 0.34

Debt / Equity Ratio 0.00

Debt / EBITDA -0.31

Debt / FCF -0.35

OCF / Debt -2.85

Interest Coverage 0.00

Altman Z-Score 21.43

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 2.5%

Return on Equity 2.7%

Return on Invested Capital -0.3%

Return on Capital Employed -0.3%

Return on Tangible Assets 2.5%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $8.05

Graham Upside -21.1%

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $0.00

Price Target Upside N/A

Cash Flow

Operating Cash Flow $-1.28M

Free Cash Flow $-1.28M

Adj. Free Cash Flow $-1.28M

FCF Per Share -$0.02

OCF Per Share -$0.02

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-1.45M

EBITDA $-1.45M

Net Income $13.02M

EPS (Diluted) $0.29

Revenue / Employee N/A

Profit / Employee $6.51M

Employees 2